Viewing Opinion | StockChase
Johnson & Johnson (JNJ-N) opinion on 2017-05-16

Last Price Recorded: 137.2900 on 2017-11-23

ON STOCKCHASE SINCE Oct 2000

biotechnology/pharmaceutical
TOP PICK

Christine Poole
Johnson & Johnson was $127.770 at time of opinion
Owned : Yes

A large, global, pharmaceutical company. The primary reason she likes this is that their pharma division is doing really, really well. They’ve had a very successful 5 years, and suspects they have a strong enough pipeline to keep that growth going. Recently acquired a Swiss pharmaceutical company which has leading products in heart disease. AAA balance sheet. Dividend yield of 2.7%. (Analysts’ price target is $130.)

BULLISH

All opinions for JNJ-N (380)

116 BUY
17 BUY on WEAKNESS
50 COMMENT
44 DON'T BUY
27 HOLD
3 PARTIAL BUY
5 PARTIAL SELL
35 PAST TOP PICK
3 SELL
1 STRONG BUY
61 TOP PICK
3 VAGUE
6 WAIT
5 WATCH
4 WEAK BUY
View All

More experts covering JNJ-N

SAVE
Add JNJ-N to Watch List

All opinions for JNJ-N (380)

116 BUY
17 BUY on WEAKNESS
50 COMMENT
44 DON'T BUY
27 HOLD
3 PARTIAL BUY
5 PARTIAL SELL
35 PAST TOP PICK
3 SELL
1 STRONG BUY
61 TOP PICK
3 VAGUE
6 WAIT
5 WATCH
4 WEAK BUY
View All

More experts covering JNJ-N

SAVE
Add JNJ-N to Watch List

No Comments.


You must be logged in to comment.

Successfully Saved Company